![Bipolar Depression Market is expected to grow with a CAGR of 16.69% during the study period [2017-30] in 7MM, reports DelveInsight - Vimarsana News](https://vimarsana.com/images/vimarsana-bigimage.jpg)
Bipolar Depression Market is expected to grow with a CAGR of 16.69% during the study period [2017-30] in 7MM, reports DelveInsight
The by DelveInsight analyses that the market will experience a boost due to the increase in the patient pool and launch of the emerging therapies such as Abilify, Lumateperone/ITI-007, NRX-100/NRX-101, Zuranolone, SEP-4199, and Falkieri during the forecast period. The report offers insights on disease comprehension, historical and forecasted epidemiology; and Bipolar Depression market trends in the 7MM (United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan). The research report also covers the current Bipolar Depression treatment practice/algorithm, market d...
Source: prnewswire.co.uk